InBioGen Co Ltd (101140) Stock Price & News

101140:KRX

InBioGen Co Ltd

₩6,830.00

-0.29%

(-20.00) 1D

Jun 10, 3:30:30 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 101140...

Open

₩6,850

High

₩7,260

Low

₩6,320

Mkt. cap

68.60B

Avg. vol.

24.63K

Volume

6.75K

52-wk high

₩14,700

52-wk low

₩5,910

EPS

-₩1,817

Shares outstanding

10.04M

No. of employees

Open

₩6,850

High

₩7,260

Low

₩6,320

Mkt. cap

68.60B

Avg. vol.

24.63K

Volume

6.75K

52-wk high

₩14,700

52-wk low

₩5,910

EPS

-₩1,817

Shares outstanding

10.04M

No. of employees

Related stocks

008500

Iljeong Industrial Co Ltd

₩917.00

-29.08%

082800

Vivozon Pharmaceutical Co Ltd

₩3,680.00

+10.01%

225430

KMPharmaceutical Co Ltd

₩2,135.00

-0.70%

009620

Sambo Industrial Co Ltd

₩620.00

+14.81%

News stories

From sources across the web

The Business Journals

10 minutes ago

Cambridge biotech Parabilis raises $670M in record-breaking IPO

Barchart.com

24 minutes ago

Is Verisk Analytics Stock Underperforming the Dow?

Simply Wall Street

22 minutes ago

FreeCast, Inc. (NASDAQ:CAST) Is Expected To Breakeven In The Near Future

Yahoo Finance

1 hour ago

U.S.-Iran Tensions, Inflation Data and Oracle Earnings Dominate Market Focus: Dow Jones, S&P, Nasdaq, Wall Street Futures

About InBioGen Co Ltd

CEO-

Employees26

Founded1949

Headquarters-

SectorFootwear

Websitearthis.co.kr

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	1.85B	2.15B	660.60M	786.28M
Cost of goods sold	1.95B	2.27B	785.89M	956.73M
Cost of revenue	1.95B	2.27B	785.89M	956.73M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	795.51M	837.18M	807.02M	785.11M
Operating expense	907.31M	929.49M	828.17M	809.22M
Total operating expenses	2.85B	3.20B	1.61B	1.77B
Operating income	-1.00B	-1.05B	-953.45M	-979.67M
Other non operating income	31.75M	13.33M	23.65M	40.90M
EBT including unusual items	1.12B	8.17B	-12.74B	-14.68B
EBT excluding unusual items	1.12B	8.14B	-14.67B	-14.68B
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	9.26M	10.57M	9.69M	13.39M
Net income	1.12B	8.17B	-12.74B	-14.68B
Net profit margin	60.74%	380.59%	-1,929.25%	-1,866.78%
Earnings per share	-	-	-	-
Interest and investment income	205.83M	230.81M	234.89M	225.03M
Interest expense	-19.25M	-17.99M	-20.74M	-47.37M
Net interest expenses	186.59M	212.81M	214.16M	177.66M
Depreciation and amortization charges	37.47M	36.70M	-	-
EBITDA	-882.90M	-934.70M	-862.58M	-977.71M
Gain or loss from assets sale	-	-723.50K	-249.99K	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research